Eli Lilly Addresses Unauthorized Use of Experimental Weight-Loss Drug in Clinics | Retatrutide News

Eli Lilly is addressing the unauthorized promotion of its experimental weight-loss drug, Retatrutide, in Georgia clinics. This highlights the challenges...
Market News · October 20, 2026